Experiences of genetic counseling for BRCA1/2 among recently diagnosed breast cancer patients: a qualitative inquiry.
For newly diagnosed breast cancer patients, BRCA1/2 genetic counseling (GC) and/or testing has the greatest potential to affect treatment choices if it occurs prior to definitive surgery. This qualitative study sought to examine recently diagnosed breast cancer patients' experiences with pretest GC (n = 9). Study results show the primary reason most women attended GC was due to a family history of cancer. Most women expressed high levels of satisfaction with timing of GC regardless of whether they were referred prior to or after definitive surgical treatment. In this study, newly diagnosed breast cancer patients, particularly those who have already completed definitive surgery, may not be fully informed about the purpose and implications of BRCA1/2 GC and/or testing for treatment decisions had they been referred prior to definitive surgery for their breast cancer diagnosis. Thus, many women felt the information provided during GC had little utility with respect to their current breast cancer diagnosis.
Vadaparampil
Susan T
ST
College of Medicine, Department of Interdisciplinary Oncology, University of South Florida, Tampa, Florida 33612, USA. susan.vadaparampil@moffitt.org
Quinn
Gwendolyn Pickard
GP
Brzosowicz
Jennifer
J
Miree
Cheryl A
CA
D001294:Attitude to Health; D001943:Breast Neoplasms / Q000235:genetics* / Q000523:psychology*; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D005817:Genetic Counseling; D006801:Humans; D008875:Middle Aged; D011795:Surveys and Questionnaires